세계의 신경중재 기기 시장 보고서(2025년)
Neurointerventional Devices Global Market Report 2025
상품코드 : 1810973
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

신경중재 기기 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 7.2%로 36억 5,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 영상 유도 수술에 대한 선호도 증가, 신경혈관 연구에 대한 투자 증가, 새로운 신경 중재 제품의 승인 확대, 장비 제조업체간의 제휴 및 인수합병 확대, 개인 맞춤형 치료 접근법에 대한 수요 증가 등에 기인합니다. 이 기간의 주요 동향으로는 로봇 보조 신경중재술의 발전, 카테터 및 스텐트 설계의 혁신, 영상 진단의 인공지능 통합 강화, 수술 계획의 증강현실 도입, 색전술 및 혈전제거술의 개발 등이 있습니다.

신경질환 유병률 증가는 향후 신경중재치료기기 시장의 성장을 가속할 것으로 예측됩니다. 신경질환은 뇌, 척수, 신경에 영향을 미쳐 정상적인 기능을 저해하는 모든 질환을 포함합니다. 노화가 진행되면 뇌 기능 및 세포 복구의 자연적 저하로 인해 신경 퇴행성 질환의 위험이 높아지기 때문입니다. 신경중재치료기기는 뇌동맥류, 뇌졸중, 혈관기형 등의 상태를 진단하고 관리하기 위한 최소침습적 시술을 가능하게 함으로써 신경질환의 치료를 돕습니다. 예를 들어 미국 비영리단체인 알츠하이머병 협회의 보고서에 따르면 2022년 65세 이상 미국인 중 알츠하이머병 진단을 받은 사람은 650만 명이며, 2024년에는 690만 명으로 늘어날 것으로 예상했습니다. 따라서 신경질환 발생률 증가가 신경중재치료기기 시장을 주도하고 있습니다.

신경중재치료기기 시장의 주요 기업은 복잡한 신경혈관 치료에서 시술 정확도 향상, 시술 시간 단축, 환자 예후 개선을 위해 AI 지원 내비게이션 시스템 등 기술 혁신에 집중하고 있습니다. AI 지원 내비게이션 시스템은 인공지능 알고리즘을 사용하여 의료 영상 데이터를 분석하여 신경 중재 시술을 실시간으로 안내합니다. 이러한 시스템은 시각화를 강화하고, 경로 계획을 자동화하며, 복잡한 뇌혈관 시스템을 정확하게 탐색할 수 있도록 지원함으로써 정확도 향상, 시술 시간 단축, 위험 최소화를 실현합니다. 예를 들어 2022년 10월 아일랜드에 본사를 둔 헬스케어 기술 기업 Medtronic plc는 뇌졸중 치료의 혁신을 가속화하기 위해 Medtronic Neurovascular Co Lab Platform을 출범했습니다. 이 플랫폼은 아이디어 제출을 위한 지속적인 가상 포털을 제공하여 스타트업, 의사, 의료기관의 협업을 촉진하고, 유망 신경혈관 솔루션을 신속하게 개발하여 환자 치료를 개선하기 위해 메드트로닉의 전문 지식, 자금, 네트워크를 통해 심사 및 지원을 받을 수 있도록 합니다. 을 통해 심사 및 지원됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Neurointerventional devices are specialized medical instruments designed for minimally invasive procedures aimed at diagnosing and treating disorders of the blood vessels in the brain, spine, head, and neck. Their main function is to restore or enhance blood flow, remove clots, repair aneurysms, or address vascular malformations without requiring open surgery.

The primary types of neurointerventional devices include embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, flow diverters, intrasaccular devices, and others. Embolic coils are small, flexible metal devices used to block blood flow within aneurysms or abnormal vessels, encouraging clot formation to prevent rupture or bleeding. These devices are indicated for conditions such as brain aneurysms and strokes and are utilized through techniques like neurothrombectomy, cerebral angiography, stenting, coiling procedures, and flow disruption. The main end users consist of hospitals, ambulatory surgical centers, specialty clinics, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The neurointerventional devices market research report is one of a series of new reports from The Business Research Company that provides neurointerventional devices market statistics, including the neurointerventional devices industry global market size, regional shares, competitors with the neurointerventional devices market share, detailed neurointerventional devices market segments, market trends, and opportunities, and any further data you may need to thrive in the neurointerventional devices industry. This neurointerventional devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurointerventional devices market size has grown strongly in recent years. It will grow from $2.57 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to rising awareness of early diagnosis, an increasing number of specialized neurointerventional centers, a higher prevalence of lifestyle-related diseases like hypertension and diabetes, growing demand for better patient outcomes, and strengthened support from public and private health organizations.

The neurointerventional devices market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth projected for the forecast period can be attributed to the increasing preference for image-guided surgeries, rising investment in neurovascular research, growing approvals of novel neurointerventional products, expanding partnerships and acquisitions among device manufacturers, and heightened demand for personalized treatment approaches. Key trends during this period include advancements in robotic-assisted neurointerventions, innovations in catheter and stent design, enhanced integration of artificial intelligence in diagnostic imaging, incorporation of augmented reality in surgical planning, and developments in embolization and thrombectomy techniques.

The increasing incidence of neurological disorders is expected to drive growth in the neurointerventional devices market going forward. Neurological disorders encompass any conditions affecting the brain, spinal cord, or nerves that disrupt normal functioning. This rise is largely attributed to an aging global population, as advancing age heightens the risk of neurodegenerative diseases due to natural declines in brain function and cellular repair. Neurointerventional devices assist in treating neurological disorders by enabling minimally invasive procedures to diagnose and manage conditions like brain aneurysms, strokes, and vascular malformations, which reduces risks, shortens recovery time, and improves patient outcomes. For example, according to a report by the Alzheimer's Association, a US-based nonprofit, 6.5 million Americans aged 65 and older were diagnosed with Alzheimer's dementia in 2022, rising to 6.9 million in 2024. Therefore, the growing incidence of neurological disorders is driving the neurointerventional devices market.

Key players in the neurointerventional devices market are focusing on technological innovations such as AI-assisted navigation systems to improve procedural accuracy, reduce intervention time, and enhance patient outcomes in complex neurovascular treatments. AI-assisted navigation systems use artificial intelligence algorithms to guide neurointerventional procedures in real time by analyzing medical imaging data. These systems provide enhanced visualization, automate path planning, and assist in accurately navigating devices through intricate brain vasculature, thereby increasing precision, shortening procedure durations, and minimizing risks. For instance, in October 2022, Medtronic plc, an Ireland-based healthcare technology company, launched the Medtronic Neurovascular Co Lab Platform to accelerate stroke treatment innovation. This platform encourages collaboration among startups, physicians, and institutions by offering a continuous virtual portal for submitting ideas, which are reviewed and supported through Medtronic's expertise, funding, and network to rapidly develop promising neurovascular solutions and improve patient care.

In September 2024, Boston Scientific, a US-based medical technology company, acquired Silk Road Medical for approximately $1.18 billion. Through this acquisition, Boston Scientific aims to broaden its vascular surgery portfolio, strengthen its stroke prevention offerings, and accelerate its mission to transform treatment approaches for vascular disease. Silk Road Medical is a US-based company specializing in medical devices such as transcarotid artery revascularization systems, including the ENROUTE transcarotid neuroprotection and stent systems.

Major players in the neurointerventional devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Integra LifeSciences Holdings Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., MicroVention Inc., Phenox GmbH, Balton Sp. z o.o., Zylox-Tonbridge Medical Technology Co. Ltd., Balt Group SAS, Veiva Scientific Co. Ltd., and InspireMD Inc.

North America was the largest region in the neurointerventional market in 2024. The regions covered in neurointerventional devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurointerventional devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurointerventional devices market consists of sales of catheters, stents, embolic coils, thrombectomy devices, and guidewires. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurointerventional Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurointerventional devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for neurointerventional devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurointerventional devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Neurointerventional Devices Market Characteristics

3. Neurointerventional Devices Market Trends And Strategies

4. Neurointerventional Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neurointerventional Devices Growth Analysis And Strategic Analysis Framework

6. Neurointerventional Devices Market Segmentation

7. Neurointerventional Devices Market Regional And Country Analysis

8. Asia-Pacific Neurointerventional Devices Market

9. China Neurointerventional Devices Market

10. India Neurointerventional Devices Market

11. Japan Neurointerventional Devices Market

12. Australia Neurointerventional Devices Market

13. Indonesia Neurointerventional Devices Market

14. South Korea Neurointerventional Devices Market

15. Western Europe Neurointerventional Devices Market

16. UK Neurointerventional Devices Market

17. Germany Neurointerventional Devices Market

18. France Neurointerventional Devices Market

19. Italy Neurointerventional Devices Market

20. Spain Neurointerventional Devices Market

21. Eastern Europe Neurointerventional Devices Market

22. Russia Neurointerventional Devices Market

23. North America Neurointerventional Devices Market

24. USA Neurointerventional Devices Market

25. Canada Neurointerventional Devices Market

26. South America Neurointerventional Devices Market

27. Brazil Neurointerventional Devices Market

28. Middle East Neurointerventional Devices Market

29. Africa Neurointerventional Devices Market

30. Neurointerventional Devices Market Competitive Landscape And Company Profiles

31. Neurointerventional Devices Market Other Major And Innovative Companies

32. Global Neurointerventional Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurointerventional Devices Market

34. Recent Developments In The Neurointerventional Devices Market

35. Neurointerventional Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기